Clinical Trial Update: SOFA: Study on Omega-3 Fatty Acids and Ventricular Arrhythmia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating omega-3 fatty acids for ventricular arrhythmia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Ventricular Arrhythmia

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Wageningen Centre for Food Sciences | Conditions: Arrhythmia | Phase 3 | Status: COMPLETED